+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Toxoid"

From
From
H1N1 Vaccines: Global Strategic Business Report - Product Thumbnail Image

H1N1 Vaccines: Global Strategic Business Report

  • Report
  • April 2024
  • 268 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
Global Vaccines Market Overview, 2023-28 - Product Thumbnail Image

Global Vaccines Market Overview, 2023-28

  • Report
  • September 2023
  • 114 Pages
  • Global
From
Global Vaccines Market Outlook, 2028 - Product Thumbnail Image

Global Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 194 Pages
  • Global
From
Middle East & Africa Vaccines Market Outlook, 2028 - Product Thumbnail Image

Middle East & Africa Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 87 Pages
  • Middle East, Africa
From
Loading Indicator

Toxoid vaccines are a type of vaccine that use a modified form of a toxin or toxin-producing microorganism to stimulate the body's immune system to produce antibodies against the toxin. The toxin is usually inactivated or weakened so that it does not cause disease, but still stimulates the body's immune system to produce antibodies. Toxoid vaccines are used to protect against a variety of diseases, including diphtheria, tetanus, and pertussis. Toxoid vaccines are widely used in both developed and developing countries, and are an important part of routine immunization programs. They are also used in the prevention of certain occupational diseases, such as tetanus in healthcare workers. The toxoid vaccine market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more